Make post-op compliance for cataract patients easier with Dexycu, an innovative FDA-approved steroid medication intended for injection into the posterior chamber after surgery. Dexycu contains extended release dexamethasone, which releases slowly into the ocular tissues over time, making patients much less likely to have to use drops. In a randomized, double-masked, placebo-controlled trial comparing Dexycu to vehicle, the Dexycu patients were much less likely to require additional topical medication. Dexycu kits come with a vial and a sterile syringe for withdrawing the drug and a bent cannula for injection.
Your product information request has been received and we will forward information to the contact information you provided shortly.